| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |